Citrate alterations in primary and metastatic human prostatic adenocarcinomas:1H magnetic resonance spectroscopy and biochemical study

Autor: Perinchery Narayan, Lee‐Hong ‐H Chang, Thomas L. James, Rajvir Dahiya, Jeffrey M. Macdonald, John Kurhanewicz
Rok vydání: 1993
Předmět:
Zdroj: Magnetic Resonance in Medicine. 29:149-157
ISSN: 1522-2594
0740-3194
DOI: 10.1002/mrm.1910290202
Popis: The objectives of this study were to quantitatively verify the low levels of citrate previously observed in primary human prostatic adenocarcinomas and to determine whether citrate was further reduced in metastatic prostatic cancer. This was accomplished by comparison of citrate concentrations of DU 145 xenografts (a poorly differentiated human prostatic adenocarcinoma cell line grown in nude mice) with concentrations in primary human adenocarcinomas. Following in vivo 1H NMR studies of DU 145 xenografts, citrate concentrations of DU 145 xenografts and surgically removed primary prostatic adenocarcinoma tissue were determined by quantitative high resolution 1H NMR and enzymatic assay. The most significant findings of this study were that citrate concentrations in primary human adenocarcinomas (3.74 +/- 0.19 mumol/g wet weight) were significantly lower than those observed for normal and benign hyperplastic (BPH) prostatic tissues. Furthermore there was a further ten-fold reduction of citrate associated with DU 145 xenografts (0.31 +/- 0.028 mumole/g wet weight) compared with primary prostatic cancer. DU 145 xenografts also exhibited higher levels of uridine diphosphosugars and choline containing metabolites relative to primary prostatic adenocarcinomas. These findings support the hypothesis that citrate is low in primary prostatic cancer and further reduced in metastatic disease.
Databáze: OpenAIRE
Externí odkaz: